{"id":132013,"date":"2017-07-31T14:48:04","date_gmt":"2017-07-31T14:48:04","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=132013"},"modified":"2017-07-31T14:48:04","modified_gmt":"2017-07-31T14:48:04","slug":"pharma-clinical-trial-services-market-and-industry-forecast-20172027","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/pharma-clinical-trial-services-market-and-industry-forecast-20172027_132013.html","title":{"rendered":"Pharma Clinical Trial Services Market And Industry Forecast 2017-2027"},"content":{"rendered":"<div style=\" width:250px; padding:8px 10px 10px 10px; float:right;\"><a href=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/07\/1501249762.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"image\" src=\"http:\/\/www.abnewswire.com\/pressreleases\/wp-content\/uploads\/2017\/07\/1501249762.png\" alt=\"\" width=\"225\" height=\"137\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\" style=\" font-weight:bold; font-style:italic;\">\n<div>&#8220;Global Clinical Trials Services other end users Submarket by region (% share) 2016-2027.&#8221;<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Visiongain launches new report entitled Pharma Clinical Trial Services Market And Industry Forecast 2017-2027: <\/p>\n<p>Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, Cardiovascular Diseases, CNS, Infectious Diseases, Metabolic Diseases, Other Diseases<\/p><\/div>\n<p style=\"text-align: justify;\">The pharma clinical trial services market is expected to grow at a CAGR of 9.5% in the first half of the forecast period. The market is expected to grow at a CAGR of 9.8% from 2016-2027. The pharma clinical trial services market is estimated at $39.56bn in 2016 dominated by the late-phase services, which held 56% of share.<\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">In this brand new<strong>&nbsp;188-page report<\/strong>&nbsp;you will receive&nbsp;<strong>145 charts&nbsp;<\/strong>&ndash; all unavailable elsewhere.<\/p>\n<p style=\"text-align: justify;\">The 188-page report provides clear detailed insight into the pharma clinical trial services market. Discover the key drivers and challenges affecting the market.<\/p>\n<p style=\"text-align: justify;\">How does this report deliver?&nbsp;<\/p>\n<p style=\"text-align: justify;\">&bull;&nbsp;<strong>Pharma Clinical Trial Services Market forecasts&nbsp;<\/strong>from&nbsp;<strong>2017-2027<\/strong><\/p>\n<p style=\"text-align: justify;\">&bull; This report breaks down the revenue forecast for pharma clinical trial services market&nbsp;<strong>by type of service<\/strong>:<br \/><strong>&bull; Early Phase Services<br \/>&bull; Late Phase Services<br \/>&bull; Other Services<\/strong><\/p>\n<p style=\"text-align: justify;\">Each submarket is&nbsp;<strong>further divided by region<\/strong>: North America, Europe, Asia-Pacific and RoW<\/p>\n<p style=\"text-align: justify;\">&bull; This report breaks down the revenue forecast for pharma clinical trial services market&nbsp;<strong>by End-Users<\/strong>:<br \/><strong>&bull; Pharma<br \/>&bull; Biotech Companies<br \/>&bull; Other End-Users<\/strong><\/p>\n<p style=\"text-align: justify;\">Each submarket is further divided by region: North America, Europe, Asia-Pacific and RoW<\/p>\n<p style=\"text-align: justify;\">&bull; This report breaks down the revenue forecast for pharma clinical trial services market&nbsp;<strong>by Therapeutic Area<\/strong>:<br \/><strong>&bull; Cancer<br \/>&bull; Cardiovascular<br \/>&bull; CNS<br \/>&bull; Infectious Diseases<br \/>&bull; Metabolic Diseases<br \/>&bull; Other Diseases<\/strong><\/p>\n<p style=\"text-align: justify;\">Each submarket is<strong>&nbsp;further divided by region<\/strong>: North America, Europe, Asia-Pacific and RoW<\/p>\n<p style=\"text-align: justify;\">&bull; This report provides individual revenue forecasts to 2027 for these&nbsp;<strong>regional and national markets<\/strong>:<br \/><strong>&bull; North America: the US and Rest of North America<br \/>&bull; Europe: France, Germany, the UK, Spain, Italy, Russia, Central and Eastern Europe, Rest of Europe<br \/>&bull; Asia-Pacific: China, India, Japan, South Korea, Rest of APAC<br \/>&bull; Rest of the World: Latin America, Middle East and Africa, Brazil<\/strong><\/p>\n<p style=\"text-align: justify;\">Each regional market is&nbsp;<strong>further divided by type of service, end-users and therapeutic area<\/strong>.<\/p>\n<p style=\"text-align: justify;\">&bull; Our study discusses<strong>&nbsp;factors that drive and restrain<\/strong>&nbsp;the pharma clinical trial services market. This report also provides a&nbsp;<strong>STEP analysis<\/strong><\/p>\n<p style=\"text-align: justify;\">&bull; This report discusses the&nbsp;<strong>leading companies<\/strong>&nbsp;in pharma clinical trial services market:<br \/>&bull; Quintiles IMS Holdings Inc.<br \/>&bull; LabCorp (Covance Inc.)<br \/>&bull; Pharmaceutical Product Development (PPD), LLC<br \/>&bull; Parexel International Corporation<br \/>&bull; ICON<br \/>&bull; INC Research<br \/>&bull; inVentiv Health<br \/>&bull; PRA Health Sciences<br \/>&bull; Chiltern International<br \/>&bull; Charles River Laboratories<\/p>\n<p style=\"text-align: justify;\">Visiongain&rsquo;s study is intended for anyone requiring commercial analyses for the pharma clinical trial services market. You find data, trends and predictions.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> Visiongain Limited<br \/><strong>Contact Person:<\/strong> Sara Peerun<br \/><strong>Email:<\/strong> sara.peerun@visiongain.com<br \/><strong>Phone:<\/strong> +44 207 3366100<br \/><strong>Address:<\/strong>143 Airport House, Purley way  <br \/><strong>City:<\/strong> London CR0 0XZ<br \/><strong>Country:<\/strong> United Kingdom<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.visiongain.com\/Report\/1931\/Pharma-Clinical-Trial-Services-Market-and-Industry-Forecast-2017-2027\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.visiongain.com\/Report\/1931\/Pharma-Clinical-Trial-Services-Market-and-Industry-Forecast-2017-2027<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.visiongain.com\/Report\/1931\/Pharma-Clinical-Trial-Services-Market-and-Industry-Forecast-2017-2027\" style=\"width:605px; height:400px;\"><\/object><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=pharma-clinical-trial-services-market-and-industry-forecast-20172027\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Global Clinical Trials Services other end users Submarket by region (% share) 2016-2027.&#8221; Visiongain launches new report entitled Pharma Clinical Trial Services Market And Industry Forecast 2017-2027: Early Phase Services, Late Phase Services, Other Services, Pharma, Biotech, Other End-Users, Cancer, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/pharma-clinical-trial-services-market-and-industry-forecast-20172027_132013.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401],"tags":[],"class_list":["post-132013","post","type-post","status-publish","format-standard","hentry","category-Business"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/132013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=132013"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/132013\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=132013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=132013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=132013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}